1-201781012-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001389617.1(NAV1):āc.2227C>Gā(p.Leu743Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,452,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001389617.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAV1 | NM_001389617.1 | c.2227C>G | p.Leu743Val | missense_variant, splice_region_variant | 9/34 | ENST00000685211.1 | NP_001376546.1 | |
IPO9-AS1 | NR_046696.1 | n.684+36215G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAV1 | ENST00000685211.1 | c.2227C>G | p.Leu743Val | missense_variant, splice_region_variant | 9/34 | NM_001389617.1 | ENSP00000510803 | P2 | ||
IPO9-AS1 | ENST00000413035.5 | n.684+36215G>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000820 AC: 2AN: 243880Hom.: 0 AF XY: 0.00000758 AC XY: 1AN XY: 131888
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1452702Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 722016
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | The c.1366C>G (p.L456V) alteration is located in exon 5 (coding exon 5) of the NAV1 gene. This alteration results from a C to G substitution at nucleotide position 1366, causing the leucine (L) at amino acid position 456 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at